SCHEMBL208290

SCHEMBL208290

CC(C)(C)N1CCN(C(=O)c2ccc(-c3ccc(CC4CCN(C5CCCCC5)C4=O)c(OC(F)(F)F)c3)cc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.38
HRH3 Q9Y5N1 4/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A7 Q99884 1/20 0.36
KCNH2 Q12809 1/20 0.36
PDE4B Q07343 1/20 0.34
PDE4D Q08499 1/20 0.34
FASN P49327 1/20 0.33
MGLL Q99685 1/20 0.33
GHSR Q92847 1/20 0.33
PKM P14618 1/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208203 0.92 EPHX2 (0.40) HSD11B1HRH3SLC6A4SLC6A7KCNH2
SCHEMBL207750 0.90 EPHX2 (0.43) HSD11B1HRH3SLC6A4SLC6A7
SCHEMBL208314 0.89 HSD11B1 (0.38) HSD11B1HRH3SLC6A4SLC6A7FASN
SCHEMBL209411 0.89 HSD11B1 (0.39) HSD11B1HRH3SLC6A4SLC6A7MGLL
SCHEMBL14391256 0.89 HSD11B1 (0.39) HSD11B1HRH3SLC6A4SLC6A7KCNH2
SCHEMBL209250 0.89 EPHX2 (0.40) HSD11B1HRH3SLC6A4KCNH2
SCHEMBL209852 0.88 HSD11B1 (0.37) HSD11B1HRH3SLC6A4SLC6A7KCNH2
SCHEMBL209360 0.88 HSD11B1 (0.38) HSD11B1HRH3SLC6A4SLC6A7PDE4B
SCHEMBL208261 0.88 HSD11B1 (0.38) HSD11B1HRH3SLC6A4SLC6A7PDE4B
SCHEMBL208882 0.88 HSD11B1 (0.39) HSD11B1HRH3SLC6A4SLC6A7KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP claimed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US claimed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US claimed
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
WO-2007124337-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885HRH3 1964/4885SLC6A4 3189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.